Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori

被引:79
作者
Nagahara, N
Akiyama, Y
Nakao, M
Tada, M
Kitano, M
Ogawa, Y
机构
[1] Takeda Chem Ind Ltd, Div Pharmaceut Res, DDS Res Labs, Yodogawa Ku, Osaka 532, Japan
[2] Takeda Chem Ind Ltd, Div Pharmaceut Res, Pharmacol Labs, Osaka 532, Japan
关键词
D O I
10.1128/AAC.42.10.2492
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In an effort to augment the anti-Helicobacter pylori effect of amoxicillin, mucoadhesive microspheres, which have the ability to reside in the gastrointestinal tract for an extended period, were prepared. The microspheres contained the antimicrobial agent and an adhesive polymer (carboxyvinyl polymer) powder dispersed in waxy hydrogenated castor ail, The percentage of amoxicillin remaining in the stomach both 2 and 4 h after oral administration of the mucoadhesive microspheres to h Mongolian gerbils under fed conditions was about three times higher than that after administration in the form of a 0.5% methylcellulose suspension. The in vivo clearance of EI, pylori following oral administration of the mucoadhesive microspheres and the 0.5% methylcellulose suspension to infected Mongolian gerbils was examined under fed conditions. The mucoadhesive microspheres and the 0.5% methylcellulose suspension both showed anti-H, pylori effects in this experimental model of infection, but the required dose of amoxicillin was effectively reduced by a factor of 10 when the mucoadhesive microspheres were used, In conclusion, the mucoadhesive microspheres more effectively cleared ii. pylori from the gastrointestinal tract than the 0.5% methylcellulose suspension due to the prolonged gastrointestinal residence time resulting from mucoadhesion, A dosage form consisting of mucoadhesive microspheres containing an appropriate antimicrobial agent should be useful for the eradication of fi, pylori.
引用
收藏
页码:2492 / 2494
页数:3
相关论文
共 23 条
[1]  
Adamek RJ, 1996, AM J GASTROENTEROL, V91, P98
[2]   NOVEL ORAL CONTROLLED-RELEASE MICROSPHERES USING POLYGLYCEROL ESTERS OF FATTY-ACIDS [J].
AKIYAMA, Y ;
YOSHIOKA, M ;
HORIBE, H ;
HIRAI, S ;
KITAMORI, N ;
TOGUCHI, H .
JOURNAL OF CONTROLLED RELEASE, 1993, 26 (01) :1-10
[3]   Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites [J].
Akiyama, Y ;
Nagahara, N ;
Nara, E ;
Kitano, M ;
Iwasa, S ;
Yamamoto, I ;
Azuma, J ;
Ogawa, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (02) :159-166
[4]   IN-VITRO AND IN-VIVO EVALUATION OF MUCOADHESIVE MICROSPHERES PREPARED FOR THE GASTROINTESTINAL-TRACT USING POLYGLYCEROL ESTERS OF FATTY-ACIDS AND A POLY(ACRYLIC ACID) DERIVATIVE [J].
AKIYAMA, Y ;
NAGAHARA, N ;
KASHIHARA, T ;
HIRAI, S ;
TOGUCHI, H .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :397-405
[5]   THE ROLE OF ACID INHIBITION IN THE TREATMENT OF HELICOBACTER-PYLORI INFECTION [J].
AXON, ATR .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 :16-23
[6]   DOUBLE-BLIND TRIAL OF OMEPRAZOLE AND AMOXICILLIN TO CURE HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH DUODENAL-ULCERS [J].
BAYERDORFFER, E ;
MIEHLKE, S ;
MANNES, GA ;
SOMMER, A ;
HOCHTER, W ;
WEINGART, J ;
HELDWEIN, W ;
KLANN, H ;
SIMON, T ;
SCHMITT, W ;
BASTLEIN, E ;
EIMILLER, A ;
HATZ, R ;
LEHN, N ;
DIRSCHEDL, P ;
STOLTE, M .
GASTROENTEROLOGY, 1995, 108 (05) :1412-1417
[7]  
BELL GD, 1992, ALIMENT PHARM THERAP, V6, P751
[8]  
CHIBA N, 1992, AM J GASTROENTEROL, V87, P1716
[9]   LOCAL GASTRIC AND SERUM AMOXICILLIN CONCENTRATIONS AFTER DIFFERENT ORAL APPLICATION FORMS [J].
COOREMAN, MP ;
KRAUSGRILL, P ;
HENGELS, KJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) :1506-1509
[10]   Kill kinetics of antimicrobial agents against Helicobacter pylori [J].
Flamm, RK ;
Beyer, J ;
Tanaka, SK ;
Clement, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (04) :719-725